Obstructive Sleep Apnea in World Trade Center Responders
Primary Purpose
Obstructive Sleep Apnea
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Standard CPAP
CPAP - Flex
Sponsored by
About this trial
This is an interventional treatment trial for Obstructive Sleep Apnea focused on measuring World Trade Center (WTC), nasal symptoms, nasal inflammation, CPAP
Eligibility Criteria
Inclusion Criteria:
- Member of the World Trade Center Health Program at either the Environmental and Occupational Healthy Sciences Institute at Robert Wood Johnson Medical School in Piscataway, NJ, the New York University School of Medicine Clinical Center of Excellence at Bellevue Hospital in New York, NY, or the Icahn School of Medicine at Mount Sinai.
Exclusion Criteria:
- Gross skeletal alterations affecting the upper airway (nose and throat)
- Unstable chronic medical conditions known to affect Obstructive Sleep Apnea (congestive heart failure, stroke)
- Pregnancy or intent to become pregnant
- Habitual snoring or diagnosis of obstructive sleep apnea prior to 9/11/2001.
Sites / Locations
- Environmental and Occupational Health Sciences Institute
- New York University School of Medicine Clinical Center of Excellence
- Mount Sinai School of Medicine
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Standard CPAP
CPAP - Flex
Arm Description
Use of a standard CPAP (continuous positive airway pressure) device with constant pressure for 4 weeks to improve breathing during sleep
Use of CPAP-Flex (continuous positive airway pressure) device with decreased pressure during expiration for 4 weeks to improve breathing during sleep
Outcomes
Primary Outcome Measures
Adherence to CPAP Pre-crossover
The use (number of hours per night) will be compared between standard CPAP and CPAP flex. Results are based on the first treatment period only (pre-crossover).
Adherence to CPAP Overall Study
The use (number of hours per night) will be compared between standard CPAP and CPAP flex. Results are based on both periods.
Secondary Outcome Measures
CPAP Efficacy
Efficacy will be evaluated by measuring the residual apnea and hypopnea index (AHI) while on treatment. The efficacy of standard CPAP and CPAP-flex will be compared. Results are based on the first treatment period only (pre-crossover).
CPAP Efficacy
Efficacy will be evaluated by measuring the residual apnea and hypopnea index (AHI) while on treatment. The efficacy of standard CPAP and CPAP-flex will be compared. Results are based on both treatment periods.
Full Information
NCT ID
NCT01753999
First Posted
December 17, 2012
Last Updated
October 10, 2020
Sponsor
Rutgers, The State University of New Jersey
Collaborators
NYU Langone Health
1. Study Identification
Unique Protocol Identification Number
NCT01753999
Brief Title
Obstructive Sleep Apnea in World Trade Center Responders
Official Title
Obstructive Sleep Apnea in WTC Responders: Role of Nasal Pathology
Study Type
Interventional
2. Study Status
Record Verification Date
October 2020
Overall Recruitment Status
Completed
Study Start Date
December 2012 (Actual)
Primary Completion Date
March 2017 (Actual)
Study Completion Date
March 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rutgers, The State University of New Jersey
Collaborators
NYU Langone Health
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The goal of the study is to examine the possible underlying causes of sleep apnea (a disorder in which there are problems with breathing during sleep) in World Trade Center Responders. The study will look at the relationship between sleep apnea and various nose and throat conditions. Specifically, the study will look at upper airway disease (problems with the nose and throat), nasal inflammation, and nasal resistance (the amount of airflow through the nose). Subjects will have a physical exam and answer questions about nasal symptoms and sleeping problems. Nasal lavage (washing the inner nasal passages) will be performed on the subjects and markers of inflammation will be measured in the lavage fluid. Rhinomanometry (measuring the airflow through the nose) will also be performed to measure the degree of airflow obstruction. All subjects will be asked to perform in-home sleep apnea monitoring. Those subjects who are diagnosed with sleep apnea will test two treatment methods. Sleep apnea is treated by using a CPAP (continuous positive airway pressure) device. This device blows air into a mask worn by the patient during sleep. The two treatment methods that will be tested are the fixed pressure CPAP (pressure is constant during use) and CPAP-flex (pressure decreases when the subject exhales). Patients will be randomly assigned to one treatment method for one month then crossed to the other treatment method for the next month. The investigators will determine if patients with certain nasal conditions (high nasal resistance) are more likely to use CPAP-flex rather than CPAP.
Detailed Description
Following the World Trade Center (WTC) disaster, an estimated 40,000 individuals were exposed to significant amounts of dust while working in rescue, recovery and debris removal. A significant number of these responders have reported least one new or worsened upper airway respiratory symptom when examined in 2004 with 50% of responders continuing to have symptoms of chronic rhino-sinusitis or upper airway disease (UAD) in 2007. In addition, about 50% of those with UAD referred to our sleep center reported new onset snoring on their questionnaires immediately following their exposure and had unusually high prevalence of obstructive sleep apnea (OSA) that did not appear to be related to obesity, which is the usual risk factor for OSA. This suggests to us that mechanisms other than obesity may be important in the pathogenesis of OSA in these subjects. Given their chronic nasal symptoms they also provide a unique opportunity to examine the relationship between nasal pathology and OSA and test if nasal symptoms reported by the subjects in the WTC Health Program (WTCHP) are an indicator of increased nasal resistance due to nasal inflammation resulting from exposure to the WTC dust. Positive Airway Pressure (CPAP) is the standard therapy for OSA but despite its efficacy has poor adherence. Subjects with high nasal resistance (such as responders with UAD and OSA) may experience additional pressure during expiration at the upper airway resulting in greater difficulty in tolerating CPAP therapy than those who do not have high nasal resistance. Reduction of excess expiratory positive pressure by the modality known as Cflex™ during CPAP therapy (CPAPFlex) may improve comfort and adherence in these subjects without compromising CPAP efficacy. In the present proposal we will study responders enrolled at the Environmental and Occupational Health Sciences Institute of Robert Wood Johnson Medical School (RWJMS) and the NYU School of Medicine Clinical Center of Excellence at Bellevue Hospital
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obstructive Sleep Apnea
Keywords
World Trade Center (WTC), nasal symptoms, nasal inflammation, CPAP
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
317 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Standard CPAP
Arm Type
Active Comparator
Arm Description
Use of a standard CPAP (continuous positive airway pressure) device with constant pressure for 4 weeks to improve breathing during sleep
Arm Title
CPAP - Flex
Arm Type
Active Comparator
Arm Description
Use of CPAP-Flex (continuous positive airway pressure) device with decreased pressure during expiration for 4 weeks to improve breathing during sleep
Intervention Type
Device
Intervention Name(s)
Standard CPAP
Other Intervention Name(s)
Philips Respironics REMstar Auto A-Flex
Intervention Description
Use of the REMstar Auto A-Flex in standard CPAP therapy mode
Intervention Type
Device
Intervention Name(s)
CPAP - Flex
Other Intervention Name(s)
Philips Respironics REMstar Auto A-Flex
Intervention Description
Use of Philips Respironics REMstar Auto A-Flex in C-Flex mode
Primary Outcome Measure Information:
Title
Adherence to CPAP Pre-crossover
Description
The use (number of hours per night) will be compared between standard CPAP and CPAP flex. Results are based on the first treatment period only (pre-crossover).
Time Frame
5 weeks after initiation of treatment
Title
Adherence to CPAP Overall Study
Description
The use (number of hours per night) will be compared between standard CPAP and CPAP flex. Results are based on both periods.
Time Frame
9 weeks after initiation of treatment
Secondary Outcome Measure Information:
Title
CPAP Efficacy
Description
Efficacy will be evaluated by measuring the residual apnea and hypopnea index (AHI) while on treatment. The efficacy of standard CPAP and CPAP-flex will be compared. Results are based on the first treatment period only (pre-crossover).
Time Frame
5 weeks after initiation of treatment
Title
CPAP Efficacy
Description
Efficacy will be evaluated by measuring the residual apnea and hypopnea index (AHI) while on treatment. The efficacy of standard CPAP and CPAP-flex will be compared. Results are based on both treatment periods.
Time Frame
9 weeks after initiation of treatment
Other Pre-specified Outcome Measures:
Title
Adherence to CPAP Overall Study, Subjects With High Nasal Resistance
Description
The use (number of hours per night) will be compared between standard CPAP and CPAP flex for subjects with high total nasal resistance (logTNR>0.8). The analysis is based on both periods.
Time Frame
9 weeks after initiation of treatment
Title
Adherence to CPAP Overall Study, Subjects With Low Nasal Resistance
Description
The use (number of hours per night) will be compared between standard CPAP and CPAP flex for subjects with low total nasal resistance (logTNR<=0.8). The analysis is based on both periods.
Time Frame
9 weeks after initiation of treatment
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Member of the World Trade Center Health Program at either the Environmental and Occupational Healthy Sciences Institute at Robert Wood Johnson Medical School in Piscataway, NJ, the New York University School of Medicine Clinical Center of Excellence at Bellevue Hospital in New York, NY, or the Icahn School of Medicine at Mount Sinai.
Exclusion Criteria:
Gross skeletal alterations affecting the upper airway (nose and throat)
Unstable chronic medical conditions known to affect Obstructive Sleep Apnea (congestive heart failure, stroke)
Pregnancy or intent to become pregnant
Habitual snoring or diagnosis of obstructive sleep apnea prior to 9/11/2001.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jag Sunderram, MD
Organizational Affiliation
Rutgers RWJMS
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Indu Ayappa, PhD
Organizational Affiliation
NYUMC
Official's Role
Principal Investigator
Facility Information:
Facility Name
Environmental and Occupational Health Sciences Institute
City
Piscataway
State/Province
New Jersey
ZIP/Postal Code
08854
Country
United States
Facility Name
New York University School of Medicine Clinical Center of Excellence
City
New York
State/Province
New York
ZIP/Postal Code
10016
Country
United States
Facility Name
Mount Sinai School of Medicine
City
New York
State/Province
New York
ZIP/Postal Code
10029
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
33202147
Citation
Sunderram J, Ayappa I, Lu SE, Wang H, Black K, Twumasi A, Sanders H, Harrison D, Udasin I, Chitkara N, de la Hoz RE, Carson JL, Rapoport DM. PAP Adherence and Nasal Resistance. A Randomized Controlled Trial of CPAPflex versus CPAP in World Trade Center Responders. Ann Am Thorac Soc. 2021 Apr;18(4):668-677. doi: 10.1513/AnnalsATS.202009-1161OC.
Results Reference
derived
PubMed Identifier
26357928
Citation
Ayappa I, Sunderram J, Black K, Twumasi A, Udasin I, Harrison D, Carson JL, Lu SE, Rapoport DM. A comparison of CPAP and CPAPFLEX in the treatment of obstructive sleep apnea in World Trade Center responders: study protocol for a randomized controlled trial. Trials. 2015 Sep 10;16:403. doi: 10.1186/s13063-015-0907-7.
Results Reference
derived
Learn more about this trial
Obstructive Sleep Apnea in World Trade Center Responders
We'll reach out to this number within 24 hrs